These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 867045)

  • 61. Somatostatin.
    Efendić S; Hökfelt T; Luft R
    Adv Metab Disord; 1978; 9():367-424. PubMed ID: 347908
    [No Abstract]   [Full Text] [Related]  

  • 62. [Somatostatin -- a review (author's transl)].
    Lucke C; Mitzkat HJ; von zur Mühlen A
    Klin Wochenschr; 1976 Apr; 54(7):293-301. PubMed ID: 1263405
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nonpeptidyl somatostatin agonists demonstrate that sst2 and sst5 inhibit stimulated growth hormone secretion from rat anterior pituitary cells.
    Parmar RM; Chan WW; Dashkevicz M; Hayes EC; Rohrer SP; Smith RG; Schaeffer JM; Blake AD
    Biochem Biophys Res Commun; 1999 Sep; 263(2):276-80. PubMed ID: 10491284
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Somatostatin: the early days.
    Guillemin R
    Digestion; 1993; 54 Suppl 1():3-6. PubMed ID: 8103012
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Comparison of the in vivo biological activity of an analog of somatostatin, D-Trp8-D-Cys14-somatostatin in 2 different pharmacological models].
    Cazaubon C; Diaz J; Gagnol JP
    C R Seances Soc Biol Fil; 1981; 175(2):200-7. PubMed ID: 6113883
    [No Abstract]   [Full Text] [Related]  

  • 66. Synthesis and conformational study of a cyclic hexapeptide analog of somatostatin containing dehydrophenylalanine.
    Brady SF; Cochran DW; Nutt RF; Holly FW; Bennett CD; Paleveda WJ; Curley PE; Arison BH; Saperstein R; Veber DF
    Int J Pept Protein Res; 1984 Feb; 23(2):212-22. PubMed ID: 6142022
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Somatostatin: hypothalamic inhibitor of the endocrine pancreas.
    Koerker DJ; Ruch W; Chideckel E; Palmer J; Goodner CJ; Ensinck J; Gale CC
    Science; 1974 Apr; 184(4135):482-4. PubMed ID: 4594711
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice.
    Strowski MZ; Parmar RM; Blake AD; Schaeffer JM
    Endocrinology; 2000 Jan; 141(1):111-7. PubMed ID: 10614629
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon secretion.
    Mandarino L; Stenner D; Blanchard W; Nissen S; Gerich J; Ling N; Brazeau P; Bohlen P; Esch F; Guillemin R
    Nature; 1981 May; 291(5810):76-7. PubMed ID: 6112710
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Somatostatin-28 is longer acting and more selective than somatostatin-14 on pituitary and pancreatic hormone release.
    Tannenbaum GS; Ling N; Brazeau P
    Endocrinology; 1982 Jul; 111(1):101-7. PubMed ID: 6123428
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Studies on the mechanism of somatostatin action on insulin release. V. Effect of somatostatin analogues on arginine induced release of insulin and glucagon from the perfused rat pancreas.
    Efendić S; Lins PE; Luft R; Sievertsson H; Westin-Sjödal G
    Acta Endocrinol (Copenh); 1977 Jul; 85(3):579-86. PubMed ID: 194446
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The biological activity of catfish pancreatic somatostatin.
    Oyama H; Martin J; Sussman K; Weir GC; Permutt A
    Regul Pept; 1981 Mar; 1(6):387-96. PubMed ID: 6112779
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [des-Ala1, Gly2]-His4,5D-Trp8-somatostatin: a glucagon-specific and long-acting somatostatin analog.
    Sarantakis D; Teichman J; Fenichel R; Lien E
    FEBS Lett; 1978 Aug; 92(2):153-5. PubMed ID: 700091
    [No Abstract]   [Full Text] [Related]  

  • 74. Inhibitory action of somatostatin on pancreatic alpha and beta cell function.
    Leblanc H; Anderson JR; Sigel MB; Yen SS
    J Clin Endocrinol Metab; 1975 Apr; 40(4):568-72. PubMed ID: 1092707
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evidence of a paracrine role for pancreatic somatostatin in vivo.
    Taborsky GJ
    Am J Physiol; 1983 Dec; 245(6):E598-603. PubMed ID: 6140853
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Suppression and stimulation of growth hormone release in sheep by somatostatin analogs.
    Redekopp C; Livesey J; Donald RA
    J Endocrinol Invest; 1984 Aug; 7(4):277-81. PubMed ID: 6150052
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synthesis and biological activity of highly potent heptapeptide analogs of somatostatin with C-terminal modifications.
    Janecka A; Zubrzycka M
    Endocr Regul; 2001 Jun; 35(2):75-9. PubMed ID: 11563935
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Selective inhibition of sleep related growth hormone release by Phe-4-somatostatin.
    Cabranes JA; Vela A; Timoneda F; Meyers CA; Coy DH; Schally AV; Charro AL
    Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):421-31. PubMed ID: 6150528
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Somatostatin analogs. Relative importance of the disulfide bridge and of the Ala-Gly side chain for biological activity.
    Rivier J; Brazeau P; Vale W; Guillemin R
    J Med Chem; 1975 Feb; 18(2):123-6. PubMed ID: 1091734
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of glucagon or somatostatin on desensitized insulin secretion.
    Bolaffi JL; Rodd G; Ma YH; Grodsky GM
    Endocrinology; 1990 Mar; 126(3):1750-5. PubMed ID: 1968383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.